New York, NY, United States of America

Huaxi Xu


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Huaxi Xu

Introduction

Huaxi Xu is a prominent inventor based in New York, NY, known for his significant contributions to the field of biomedical research. He holds two patents that focus on the prevention and treatment of amyloid-β peptide-related disorders, particularly in relation to Alzheimer's disease. His work has the potential to impact the lives of many individuals affected by neurodegenerative conditions.

Latest Patents

Huaxi Xu's latest patents include innovative methods and compositions for modulating levels of amyloid-β peptide (Aβ) exhibited by cells or tissues. These inventions provide pharmaceutical compositions and methods for screening compounds that can modulate Aβ levels. The patents also detail methods for preventing, treating, or ameliorating symptoms of disorders related to Aβ, including Alzheimer's disease, through selective modulation of ATP-dependent γ-secretase activity.

Career Highlights

Throughout his career, Huaxi Xu has worked with esteemed institutions such as The Rockefeller University and Intra-cellular Therapies, Inc. His research has been pivotal in advancing our understanding of amyloid-β peptide-related disorders and developing potential therapeutic strategies.

Collaborations

Huaxi Xu has collaborated with notable colleagues, including William Netzer and Paul Greengard, who have also made significant contributions to the field of neuroscience and Alzheimer's research.

Conclusion

Huaxi Xu's innovative work in the realm of amyloid-β peptide-related disorders showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to finding solutions for complex neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…